Sunique Bio Profile
Key Indicators
- Authorised Capital ₹ 2.50 Cr
- Paid Up Capital ₹ 2.50 Cr
- Company Age 6 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 Cr
- Revenue Growth 0.81%
- Profit Growth 31.89%
- Ebitda 211.01%
- Net Worth 0.86%
- Total Assets 8.30%
About Sunique Bio
Sunique Bio Private Limited (SBPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 March 2018 (Six years and ten months 15 days old ). Its registered office is in Hyderabad, Telangana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 Cr and a paid-up capital of Rs 2.50 Cr.
The company currently has active open charges totaling ₹2.00 Cr.
Company Details
-
Location
Hyderabad, Telangana, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U74999TG2018PTC123146
-
Company No.
123146
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Mar 2018
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Hyderabad
Industry
Who are the key members and board of directors at Sunique Bio?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Seshu Singu
|
Director | 21-Jan-2022 | Current |
|
Ranjith Kalluru
|
Director | 20-Mar-2018 | Current |
|
Amulya Rayavarapu
|
Director | 04-Feb-2021 | Current |
Financial Performance of Sunique Bio.
Sunique Bio Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 0.81% increase. The company also saw a substantial improvement in profitability, with a 31.89% increase in profit. The company's net worth moved up by a moderate rise of 0.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunique Bio?
In 2020, Sunique Bio had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Abode Biotec India Private LimitedRanjith Kalluru is a mutual person
Charges (Loans)
₹2.00 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 2.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Mar 2022 | Others | ₹2.00 Cr | Open |
How Many Employees Work at Sunique Bio?
Unlock and access historical data on people associated with Sunique Bio, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunique Bio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunique Bio's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
